SRPT Historical PE Ratio image   This SRPT PE ratio history page last updated 5/16/2024
SRPT PE History Chart
PeriodPriceAdj. EPSTTMPE
Q1 2024
5/1/2024
130.900.731.07122.3
Q4 2023
2/28/2024
137.500.82-0.63NA
Q3 2023
11/1/2023
76.520.37-1.98NA
Q2 2023
8/2/2023
105.19-0.85-3.15NA
Q1 2023
5/2/2023
123.69-0.97-3.48NA
Q4 2022
2/28/2023
122.13-0.53-3.07NA
Q3 2022
11/2/2022
113.42-0.80-3.31NA
Q2 2022
8/2/2022
94.01-1.18-2.70NA
Q1 2022
5/4/2022
72.75-0.56-3.04NA
Q4 2021
3/1/2022
76.02-0.77-4.02NA
Q3 2021
11/3/2021
86.53-0.19-5.09NA
Q2 2021
8/4/2021
67.50-1.52-6.32NA
Q1 2021
5/5/2021
72.77-1.54-6.31NA
Q4 2020
3/1/2021
87.03-1.84-5.81NA
Q3 2020
11/5/2020
145.15-1.42-5.54NA
Q2 2020
8/5/2020
158.89-1.51-5.26NA
Q1 2020
5/6/2020
122.57-1.04-4.58NA
Q4 2019
2/26/2020
113.63-1.57-4.29NA
Q3 2019
11/7/2019
93.38-1.14-3.57NA
Q2 2019
8/7/2019
142.26-0.83-2.99NA
Q1 2019
5/8/2019
114.50-0.75-2.59NA
Q4 2018
2/27/2019
151.68-0.85-2.12NA
Q3 2018
10/24/2018
123.04-0.56-1.55NA
Q2 2018
8/8/2018
121.02-0.43-1.19NA
Q1 2018
5/3/2018
78.17-0.28-1.22NA
Q4 2017
3/1/2018
62.11-0.28-1.54NA
Q3 2017
10/25/2017
48.36-0.20-1.97NA
Q2 2017
7/19/2017
34.08-0.46-2.72NA
Q1 2017
4/27/2017
34.72-0.60-3.45NA
Q4 2016
2/28/2017
31.11-0.71-4.00NA
Q3 2016
10/27/2016
40.81-0.95-4.59NA
Q2 2016
7/19/2016
21.14-1.19-4.75NA
Q1 2016
5/5/2016
16.76-1.15-4.43NA
Q4 2015
2/25/2016
14.36-1.30-4.43NA
Q3 2015
11/5/2015
24.28-1.11-4.07NA
Q2 2015
8/6/2015
34.63-0.87-3.66NA
Q1 2015
5/7/2015
15.04-1.15-3.40NA
Q4 2014
2/26/2015
13.82-0.94-2.80NA
Q3 2014
11/6/2014
16.26-0.70-2.63NA
Q2 2014
8/7/2014
19.90-0.61-2.56NA
Q1 2014
5/8/2014
31.10-0.55-2.41NA
Q4 2013
2/27/2014
29.86-0.77-2.27NA
Q3 2013
11/12/2013
13.16-0.63-3.86NA
Q2 2013
8/8/2013
36.85-0.46-5.40NA
Q1 2013
5/9/2013
33.08-0.41-4.58NA
Q4 2012
3/7/2013
30.21-2.36NANA
Q3 2012
11/7/2012
22.61-2.17NANA
Q2 2012
8/7/2012
8.310.36NANA
SRPT Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q1 2024
5/1/2024
130.900.732.9244.8
Q4 2023
2/28/2024
137.500.823.2841.9
Q3 2023
11/1/2023
76.520.371.4851.7
Q2 2023
8/2/2023
105.19-0.85-3.40NA
Q1 2023
5/2/2023
123.69-0.97-3.88NA
Q4 2022
2/28/2023
122.13-0.53-2.12NA
Q3 2022
11/2/2022
113.42-0.80-3.20NA
Q2 2022
8/2/2022
94.01-1.18-4.72NA
Q1 2022
5/4/2022
72.75-0.56-2.24NA
Q4 2021
3/1/2022
76.02-0.77-3.08NA
Q3 2021
11/3/2021
86.53-0.19-0.76NA
Q2 2021
8/4/2021
67.50-1.52-6.08NA
Q1 2021
5/5/2021
72.77-1.54-6.16NA
Q4 2020
3/1/2021
87.03-1.84-7.36NA
Q3 2020
11/5/2020
145.15-1.42-5.68NA
Q2 2020
8/5/2020
158.89-1.51-6.04NA
Q1 2020
5/6/2020
122.57-1.04-4.16NA
Q4 2019
2/26/2020
113.63-1.57-6.28NA
Q3 2019
11/7/2019
93.38-1.14-4.56NA
Q2 2019
8/7/2019
142.26-0.83-3.32NA
Q1 2019
5/8/2019
114.50-0.75-3.00NA
Q4 2018
2/27/2019
151.68-0.85-3.40NA
Q3 2018
10/24/2018
123.04-0.56-2.24NA
Q2 2018
8/8/2018
121.02-0.43-1.72NA
Q1 2018
5/3/2018
78.17-0.28-1.12NA
Q4 2017
3/1/2018
62.11-0.28-1.12NA
Q3 2017
10/25/2017
48.36-0.20-0.80NA
Q2 2017
7/19/2017
34.08-0.46-1.84NA
Q1 2017
4/27/2017
34.72-0.60-2.40NA
Q4 2016
2/28/2017
31.11-0.71-2.84NA
Q3 2016
10/27/2016
40.81-0.95-3.80NA
Q2 2016
7/19/2016
21.14-1.19-4.76NA
Q1 2016
5/5/2016
16.76-1.15-4.60NA
Q4 2015
2/25/2016
14.36-1.30-5.20NA
Q3 2015
11/5/2015
24.28-1.11-4.44NA
Q2 2015
8/6/2015
34.63-0.87-3.48NA
Q1 2015
5/7/2015
15.04-1.15-4.60NA
Q4 2014
2/26/2015
13.82-0.94-3.76NA
Q3 2014
11/6/2014
16.26-0.70-2.80NA
Q2 2014
8/7/2014
19.90-0.61-2.44NA
Q1 2014
5/8/2014
31.10-0.55-2.20NA
Q4 2013
2/27/2014
29.86-0.77-3.08NA
Q3 2013
11/12/2013
13.16-0.63-2.52NA
Q2 2013
8/8/2013
36.85-0.46-1.84NA
Q1 2013
5/9/2013
33.08-0.41-1.64NA
Q4 2012
3/7/2013
30.21-2.36-9.44NA
Q3 2012
11/7/2012
22.61-2.17-8.68NA
Q2 2012
8/7/2012
8.310.361.445.8
Quotes delayed 20 minutes

Email EnvelopeFree SRPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sarepta Therapeutics (SRPT) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

SRRA PE Ratio History
SRRK PE Ratio History
SRTS PE Ratio History
SSKN PE Ratio History
STAA PE Ratio History
STAB PE Ratio History
STE PE Ratio History
STIM PE Ratio History
STOK PE Ratio History
STRO PE Ratio History
On this page we presented the SRPT PE Ratio History information for Sarepta Therapeutics' stock. The average SRPT PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 36.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SRPT PE ratio history based on this TTM earnings result method is 122.3. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this SRPT PE ratio history result, against the recent PE: when this page was posted on 5/15/2024, the most recent closing price for SRPT had been 132.50, and the most recent quarterly earnings result, annualized, was 2.92. Meanwhile, the most recent TTM earnings summed to 1.07. From these numbers, we calculate the recent SRPT PE on 5/15/2024 based on annualized quarterly EPS was 45.4. Based on SRPT's history, that recent PE is elevated relative to the historical average, with the recent PE 26.1% higher than the historical average PE across our data set for Sarepta Therapeutics. Looking at the recent SRPT PE on 5/15/2024 based on TTM EPS, we calculate the ratio at 123.8. Based on SRPT's history, that recent PE is elevated relative to the historical average, with the recent PE 1.2% higher than the historical average PE across our Sarepta Therapeutics data set with TTM EPS used in the calculation at each period.

Another interesting SRPT PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for SRPT, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for SRPT, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.85, 0.37, 0.73, and 0.82. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.37 and 0.73 — which gives us the median of 0.55. Basically the way to think about this 0.55 number is this: for the trailing four earnings reports, 0.55 marks the "middle ground" number where SRPT has reported a value higher than 0.55 half the time, and has reported a value lower than 0.55 half the time. Annualizing that median value then gets us to 2.2/share, which we use as the denominator in our next PE calculation. With 132.50 as the numerator (as of 5/15/2024), the calculation is then 132.50 / 2.2 = 60.2 as the SRPT PE ratio as of 5/15/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on SRPT or any other given stock, valuation analysis for SRPT can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Sarepta Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for SRPT. Thanks for visiting, and the next time you need to research SRPT PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: CVTI Price Target, Top Ten Hedge Funds Holding DVCR, FFHL YTD Return.

 

SRPT PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.